Proteinase-activated receptors: Tethered ligands and receptor-activating peptides

被引:5
|
作者
Hollenberg, MD
机构
[1] Univ Calgary, Fac Med, Dept Pharmacol & Therapeut, Diabet Endocrine Grp, Calgary, AB T2N 4N1, Canada
[2] Univ Calgary, Dept Pharmacol & Therapeut, Mucosal Inflammat Grp, Calgary, AB T2N 4N1, Canada
[3] Univ Calgary, Dept Pharmacol & Therapeut, Smooth Muscle & Canc Biol Res Grp, Calgary, AB T2N 4N1, Canada
[4] Univ Calgary, Dept Med, Calgary, AB T2N 4N1, Canada
关键词
proteinases; thrombin PAR- activating peptides; inflammation; nociception; GASTRIC SMOOTH-MUSCLE; THROMBIN RECEPTOR; STRUCTURAL REQUIREMENTS; CROSS-REACTIVITY; (PAR(2))-ACTIVATING PEPTIDES; DIFFERENTIAL ACTIVATION; MOLECULAR-CLONING; DISTINCT; PAR(1); IDENTIFICATION;
D O I
10.1002/ddr.10301
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Proteinase-activated receptors (PARs), newly-discovered members of the G-protein-coupled receptor superfamily, comprising four cloned family members (PARs 1 to 4), are activated by the proteolytic unmasking of a "tethered ligand" sequence situated in the N-terminal extracellular receptor domain. Furthermore, synthetic peptides with sequences based on the revealed tethered ligands can, in the absence of proteolysis, trigger receptor signaling. This report reviews the data supporting the tethered ligand mechanism of receptor activation, outlines the utility of the receptor-activating peptides (so-called PAR-APs) for exploring the potential physiological roles of the PARs, and discusses the potential differences between the activation of the receptors via their tethered ligands as opposed to activation by the soluble peptides having the same amino acid sequences. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:336 / 343
页数:8
相关论文
共 50 条
  • [31] Proteinases, proteinase-activated receptors (PARs) and the pathophysiology of cancer and diseases of the cardiovascular, musculoskeletal, nervous and gastrointestinal systems
    Kristina K. Hansen
    Katerina Oikonomopoulou
    Yang Li
    Morley D. Hollenberg
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2008, 377 : 377 - 392
  • [32] Proteinases, proteinase-activated receptors (PARs) and the pathophysiology of cancer and diseases of the cardiovascular, musculoskeletal, nervous and gastrointestinal systems
    Hansen, Kristina K.
    Oikonomopoulou, Katerina
    Li, Yang
    Hollenberg, Morley D.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2008, 377 (4-6) : 377 - 392
  • [33] Proteinase-activated receptors regulate intestinal functions in a segment-dependent manner in rats
    Mirakhur, Maanvee
    Diener, Martin
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 933
  • [34] Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue
    Saifeddine, M
    AlAni, B
    Cheng, CH
    Wang, L
    Hollenberg, MD
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (03) : 521 - 530
  • [35] Proteinase-activated receptor-2 (PAR2) and mouse osteoblasts: Regulation of cell function and lack of specificity of PAR2-activating peptides
    Georgy, Smitha R.
    Pagel, Charles N.
    Wong, David M.
    Sivagurunathan, Sutharshani
    Loh, Lay H.
    Myers, Damian E.
    Hollenberg, Morley D.
    Pike, Robert N.
    Mackie, Eleanor J.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (03) : 328 - 336
  • [36] Proteinase-activated receptor 1 antagonism ameliorates experimental pulmonary hypertension
    Kuwabara, Yukimitsu
    Tanaka-Ishikawa, Mariko
    Abe, Kohtaro
    Hirano, Mayumi
    Hirooka, Yoshitaka
    Tsutsui, Hiroyuki
    Sunagawa, Kenji
    Hirano, Katsuya
    CARDIOVASCULAR RESEARCH, 2019, 115 (08) : 1357 - 1368
  • [37] Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo
    Nhu, Q. M.
    Shirey, K.
    Teijaro, J. R.
    Farber, D. L.
    Netzel-Arnett, S.
    Antalis, T. M.
    Fasano, A.
    Vogel, S. N.
    MUCOSAL IMMUNOLOGY, 2010, 3 (01) : 29 - 39
  • [38] Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs)
    Oikonomopoulou, Katerina
    Hansen, Kristina K.
    Saifeddine, Mahmoud
    Vergnolle, Nathalie
    Tea, Illa
    Blaber, Michael
    Blaber, Sachiko I.
    Scarisbrick, Isobel
    Diamandis, Eleftherios P.
    Hollenberg, Morley D.
    BIOLOGICAL CHEMISTRY, 2006, 387 (06) : 817 - 824
  • [39] Tethered ligand-derived peptides of proteinase-activated receptor 3 (PAR3) activate PAR1 and PAR2 in Jurkat T cells
    Hansen, KK
    Saifeddine, M
    Hollenberg, MD
    IMMUNOLOGY, 2004, 112 (02) : 183 - 190
  • [40] Novel antagonists for proteinase-activated receptor 2: inhibition of cellular and vascular responses in vitro and in vivo
    Kanke, T.
    Kabeya, M.
    Kubo, S.
    Kondo, S.
    Yasuoka, K.
    Tagashira, J.
    Ishiwata, H.
    Saka, M.
    Furuyama, T.
    Nishiyama, T.
    Doi, T.
    Hattori, Y.
    Kawabata, A.
    Cunningham, M. R.
    Plevin, R.
    BRITISH JOURNAL OF PHARMACOLOGY, 2009, 158 (01) : 361 - 371